ICRUCUMAB
UNII T7H0B1R64U

Substance Identification & Data

This profile provides standardized clinical and technical data for Icrucumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) T7H0B1R64U.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1024603-92-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

T7H0B1R64U

CAS Registry Number

1024603-92-6

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

ICRUCUMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C79808

National Cancer Institute reference terminology for clinical and research data.

INN ID

9370

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

WW-103

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Icrucumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

ICRUCUMAB

Common Names & Synonyms

ICRUCUMAB [INN]

ICRUCUMAB [USAN]

ICRUCUMAB [WHO-DD]

IMMUNOGLOBULIN G1, ANTI-(HUMAN TYPE VEGFR-1 VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR) (HUMAN MONOCLONAL 18F1 .GAMMA.-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL 18F1 .KAPPA.-CHAIN, DIMER